Qube Research & Technologies Ltd

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
2,819
Total Value
42368360846
Accession Number
0001729829-25-000048
Form Type
13F-HR
CIK
0001729829
Manager Name
Qube Research & Technologies Ltd
Data Enrichment
80% identified
2,245 identified574 unidentified

Holdings

2,819 positions
Manager:
SEC
Search and click to pin securities to the top
Page 139 of 141
92206C565
92206C565
Shares:
41(+0.0%)
Value:
$2.8M(+0.9%)
92206C573
92206C573
Shares:
35(+0.0%)
Value:
$2.7M(+1.4%)
78463X152
78463X152
Shares:
48(+0.0%)
Value:
$2.7M(+8.6%)
46137V316
46137V316
Shares:
83(+0.0%)
Value:
$2.6M(-2.5%)
74347R214
74347R214
Shares:
53(+0.0%)
Value:
$2.6M(-4.9%)
46137V738
46137V738
Shares:
40(+0.0%)
Value:
$2.4M(+4.6%)
464289479
464289479
Shares:
46(-23.3%)
Value:
$2.3M(-21.2%)
46138E115
46138E115
Shares:
57(+0.0%)
Value:
$2.3M(-16.0%)
37950E416
37950E416
Shares:
51(+0.0%)
Value:
$2.2M(+3.6%)
46429B366
46429B366
Shares:
46(+0.0%)
Value:
$2.2M(+1.7%)
46138E594
46138E594
Shares:
132(+0.0%)
Value:
$2.2M(-6.8%)
Coupang, Inc.
CPNG|22266T109
Shares:
100(-100.0%)
Value:
$2.2M(-100.0%)
53656F789
53656F789
Shares:
113(+0.0%)
Value:
$2.1M(-0.8%)
46138G847
46138G847
Shares:
197(+0.0%)
Value:
$2.1M(-8.9%)
464287556
464287556
Shares:
16(-99.0%)
Value:
$2.0M(-99.0%)
74347X815
74347X815
Shares:
96
Value:
$2.0M
Adaptimmune Therapeutics PLC
ADAP|00653A107
Shares:
10113
Value:
$2.0M
74348A210
74348A210
Shares:
92(-72.7%)
Value:
$1.9M(-69.8%)
74347R370
74347R370
Shares:
120(+0.0%)
Value:
$1.9M(-7.1%)
25460E265
25460E265
Shares:
237(-78.1%)
Value:
$1.7M(-75.2%)